SCM-010
/ Stem Cell Medicine
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 18, 2024
Study to Assess the Safety and Efficacy of an IT Administration of SCM-010 in SPMS
(clinicaltrials.gov)
- P1/2 | N=0 | Withdrawn | Sponsor: Stem Cell Medicine Ltd. | N=12 ➔ 0 | Trial completion date: Feb 2024 ➔ Feb 2025 | Not yet recruiting ➔ Withdrawn | Trial primary completion date: Feb 2024 ➔ Feb 2025
Enrollment change • Trial completion date • Trial primary completion date • Trial withdrawal • CNS Disorders • Multiple Sclerosis
October 27, 2022
Study to Assess the Safety and Efficacy of an IT Administration of SCM-010 in SPMS
(clinicaltrials.gov)
- P1/2 | N=12 | Not yet recruiting | Sponsor: Stem Cell Medicine Ltd. | Trial completion date: Feb 2021 ➔ Feb 2024 | Trial primary completion date: Feb 2021 ➔ Feb 2024
Trial completion date • Trial primary completion date • CNS Disorders • Multiple Sclerosis
1 to 2
Of
2
Go to page
1